This content has been automatically generated from the original PDF and some formatting may have been lost. Let us know if you find any major problems.
Text in this format is not official and should not be relied upon to extract citations or propose amendments. Please see the PDF for the official version of the document.
WQ.78/2024
WRITTEN QUESTION TO THE MINISTER FOR HEALTH AND SOCIAL SERVICES
BY DEPUTY I. GARDINER OF ST. HELIER NORTH
QUESTION SUBMITTED ON MONDAY 11th MARCH 2024
ANSWER TO BE TABLED ON MONDAY 18th MARCH 2024
Question
“Further to the publication of two interim reports in relation to the Infected Blood Inquiry in the UK (The Inquiry’s First Interim Report on 29th July 2022 and The Inquiry’s Second Interim Report on 5th April 2023), will the Minister state –
- what actions, if any, have been taken to contact all the patients in Jersey who were potentially affected;
- whether Jersey patients are to be included in the proposed compensation scheme and, if so, how many patients it is estimated will be supported; and
- what support is being, or has been, provided to patients in Jersey?”
Answer
- In 2019 Health and Community Services undertook a look back exercise to determine if all patients who had received potentially contaminated blood products (i.e. in the 1970s and 1980s) had in fact been screened.
Less than ten patients could not be contacted despite repeated attempts to do so. All the remaining patients were contacted if they had not already been contacted in the past. All contacted patients received the relevant follow-up and support.
- Our officials are currently in contact with the UK Government to ascertain whether Jersey patients may be admitted to the proposed UK compensation scheme.
- Patients in Jersey were offered appropriate screening and treatment where applicable. The Skipton fund was available to patients in Jersey and application to the fund was supported by clinical staff. As stated above our officials are currently in contact with the UK Government to ascertain whether Jersey patients may be admitted to the proposed UK compensation scheme. If any patient has an enquiry or requires support, they should contact the Patient Advisory Liaison Services (PALS) who are available Monday to Friday from 8am to 4pm. Please call the team on +44 (0) 1534 443515 or email: PALS@health.gov.je